Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
When evaluated by whole-body autoradiography (WBAR) and quantitative densitometry, [3H]phencyclidine (
PCP
) equivalents were found to be removed rapidly from blood, after a single iv dose in mice, and avidly taken up as early as 1 min after dosage by glandular tissues including thyroid, salivary glands, pancreas, pituitary and, most prominently, by stomach mucosa.
Stomach
:blood [3H]
PCP
concentration ratios showed that rapid secretion of [3H]
PCP
from mucosa to the stomach contents occurred within 2 min after dosing. During early intervals, chromatographic analysis of tissue sections demonstrated that
PCP
was present in brain, liver, and gut primarily in its unaltered chemical form. Mice killed at 60 and 120 min showed persistently high levels of [3H]
PCP
equivalents within the stomach and intestines, these levels being the highest of all other tissues densitometrically measured. The early time course and magnitude of [3H]
PCP
uptake by stomach glandular mucosa strongly suggests that cycling of
PCP
occurs principally through gastroenteric recirculation. Very striking was the high concentration of [3H]
PCP
radioactivity observed within the adrenal as early as 5 min. The concentration of [3H]
PCP
equivalents in pituitary, choroid plexus, cortex, hippocampus, and thalamus was highest at 1-20 min following injection. Application of high-resolution quantitative WBAR was found to be a useful tool in the study of the biodistribution of labeled
PCP
, especially during very early post-treatment time points where alternative tissue counting techniques would not be feasible.
...
PMID:Whole-body autoradiographic localization of [3H]phencyclidine and its metabolites in mice. 336 21